Sun Yat-sen University

This study tested whether adding the drug toripalimab after standard chemoradiation could help control limited-stage small cell lung cancer longer. It involved 170 patients whose cancer hadn't worsened after initial treatment. The trial was terminated before completion, so full r…

This early-stage trial tested a combination of two drugs, toripalimab and chidamide, for women with advanced cervical cancer that had returned or spread after standard chemotherapy. The goal was to see if this new drug pair could control the cancer better than existing options an…